BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2806210
Number of visits today
966
Number of downloads
2058662
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Rodrigues PM, Vogel A, Arrese M, Balderramo DC, Valle JW, Banales JM. Next-Generation Biomarkers for Cholangiocarcinoma. Cancers (Basel) 2021;13:3222. [PMID: 34203269 DOI: 10.3390/cancers13133222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Ciren P, Danzeng A, Li Y, Zeng C, Zhang Z, Huang Z, Chen Y, Zhang W, Zhang B, Zhang B, Chen X. Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/4446243] [Reference Citation Analysis]
2 Hucke F, Pinter M, Hucke M, Bota S, Bolf D, Hackl M, Peck-radosavljevic M. Changing Epidemiological Trends of Hepatobiliary Carcinomas in Austria 2010–2018. Cancers 2022;14:3093. [DOI: 10.3390/cancers14133093] [Reference Citation Analysis]
3 Yamamoto Y, Sugimoto A, Maruo K, Tsujio G, Sera T, Kushiyama S, Nishimura S, Kuroda K, Togano S, Eguchi S, Tanaka R, Kimura K, Amano R, Ohira M, Yashiro M. CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. PLoS One 2022;17:e0266027. [PMID: 35377900 DOI: 10.1371/journal.pone.0266027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liu C, Li Y, Zhang L, Zhang P, Yu N, Liu X, Lu H, Du H, Hou S, Kang Z. MiRNA-196-5p Promotes Proliferation and Migration in Cholangiocarcinoma via HAND1/Wnt/β-Catenin Signaling Pathway. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/4599676] [Reference Citation Analysis]
5 Jördens MS, Heinrichs L, Loosen SH, Wittig L, Keitel V, Schöler D, Schulze-Hagen M, Loberg C, Antoch G, Knoefel WT, Luedde T, Fluegen G, Roderburg C. Sarcopenia Predicts Cancer Mortality in Male but Not in Female Patients Undergoing Surgery for Cholangiocellular Carcinoma. Cancers (Basel) 2021;13:5359. [PMID: 34771524 DOI: 10.3390/cancers13215359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345